scholarly journals Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis

2018 ◽  
Vol 50 (2) ◽  
pp. 518-529 ◽  
Author(s):  
Jwa Hoon Kim ◽  
Sook Ryun Park ◽  
Min-Hee Ryu ◽  
Baek-Yeol Ryoo ◽  
Kyu-pyo Kim ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Induction Chemotherapy ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Paraaortic Lymph Node ◽  
Node Metastasis ◽  
Unresectable Gastric Cancer ◽  
Paraaortic Lymph Node Metastasis

scholarly journals A Case of Gastric Cancer with Invasion to the Mucosal Layer and Paraaortic Lymph Node Metastasis.

1993 ◽  
Vol 26 (12) ◽  
pp. 2822-2826
Author(s):  
Kazuomi Iwasaki ◽  
Takuo Shinozaki ◽  
Satoshi Yamaguchi ◽  
Takafumi Urakawa ◽  
Kazuya Okada ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Paraaortic Lymph Node ◽  
Node Metastasis ◽  
Mucosal Layer ◽  
Paraaortic Lymph Node Metastasis

A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis

2006 ◽  
Vol 41 (4) ◽  
pp. 391-392 ◽  
Author(s):  
Takahiro Uenishi ◽  
Osamu Yamazaki ◽  
Katsuhiko Horii ◽  
Takatsugu Yamamoto ◽  
Shoji Kubo
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Intrahepatic Cholangiocarcinoma ◽  
Paraaortic Lymph Node ◽  
Node Metastasis ◽  
Paraaortic Lymph Node Metastasis ◽  
Term Survivor

scholarly journals Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy

2020 ◽  
Vol 17 (16) ◽  
pp. 5941
Author(s):  
Hui-Hua Chen ◽  
Wan-Hua Ting ◽  
Hsu-Dong Sun ◽  
Ming-Chow Wei ◽  
Ho-Hsiung Lin ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Endometrial Cancer ◽  
Lymph Node ◽  
High Risk ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Body Mass ◽  
Paraaortic Lymph Node ◽  
Node Metastasis ◽  
Paraaortic Lymph Node Metastasis

Background: to elucidate the predictors of progression-free survival (PFS) and overall survival (OS) in high-risk endometrial cancer patients. Methods: the medical records of all consecutivewomen with high-risk endometrial cancer were reviewed. Results: among 92 high-risk endometrial cancer patients, 30 women experienced recurrence, and 21 women died. The 5-year PFS and OS probabilities were 65.3% and 75.9%, respectively. Multivariable Cox regression revealed that body mass index (hazard ratio (HR) = 1.11), paraaortic lymph node metastasis (HR = 11.11), lymphovascular space invasion (HR = 5.61), and sandwich chemoradiotherapy (HR = 0.15) were independently predictors of PFS. Body mass index (HR = 1.31), paraaortic lymph node metastasis (HR = 32.74), non-endometrioid cell type (HR = 11.31), and sandwich chemoradiotherapy (HR = 0.07) were independently predictors of OS. Among 51 women who underwent sandwich (n = 35) or concurrent (n = 16) chemoradiotherapy, the use of sandwich chemoradiotherapy were associated with better PFS (adjusted HR = 0.26, 95% CI = 0.08–0.87, p = 0.03) and OS (adjusted HR = 0.11, 95% CI = 0.02–0.71, p = 0.02) compared with concurrent chemoradiotherapy. Conclusion: compared with concurrent chemoradiotherapy, sandwich chemoradiotherapy was associated with better PFS and OS in high-risk endometrial cancer patients. In addition, high body mass index, paraaortic lymph node metastasis, and non-endometrioid cell type were also predictors of poor OS in high-risk endometrial cancer patients.

Sign in / Sign up

Export Citation Format

Share Document